TRANSFORM Position on the EU Pharmaceutical Package
TRANSFORM Alliance Members’ consensus positions in response the European Commission’s legislative proposals on the Pharmaceutical Package. These positions aim to drive positive change across the full lifecycle of ATMPs, hence they are listed according to their place in the lifecycle of a therapy, from research through to patient access, and must be viewed holistically.
TRANSFORM MEP Charter with Solutions to Enable Safe and Timely Patient Access to Advanced Therapies in Europe
On 13 October, the European Alliance for Transformative Therapies launched its MEP Charter with Solutions to Enable Safe and Timely Patient Access to Advanced Therapies in Europe, developed collaboratively with expert stakeholders. The Charter will serve as a guide for TRANSFORM’s action in the coming years, including for the MEPs to prepare the discussion of expected legislative files such as SoHO legislation, the General Pharmaceuticals legislations, the EHDS, among others.
TRANSFORM: Multi-stakeholder approach to gene and cell therapies
TRANSFORM is a multi-stakeholder alliance composed of patient groups, medical experts and associations, healthcare and non-healthcare specialists, scientists, researchers, industry actors and other relevant stakeholders. We advocate for improving the regulatory and legislative systems with the intention to realise the promise of transformative therapies for severe, disabling or life-limiting conditions.
The European Alliance for Transformative Therapies’ (TRANSFORM) Policy Asks advocate for a regulatory framework that enables safe and timely patient access to transformative therapies, building on the 2021 TRANSFORM Recommendations for Action.
The European Alliance for Transformative Therapies’ (TRANSFORM) Policy Asks advocate for changes that offer potential solutions to unlock safe and timely patient access to authorised ATMPs in Europe, building on the 2021 TRANSFORM Recommendations for Action.
5 Policy Asks to Optimize Cross-border Patient Access to Transformative Therapies
The TRANSFORM MEP Interest Group launched 5 Policy Asks on how to optimize cross-border patient access to transformative therapies at their online event on 10 November 2021.
EAHP- European Association of Hospital Pharmacists
GBS⎢CIDP Foundation International
European Society of Gene and Cell Therapy (ESGCT)
EFNA – European Federation of Neurological Associations
ReNEW Consortium – Stem Cell Medicine
RI – Retina International
WDO – World Duchenne Organization
IPOPI – International Patient Organisation for Primary Immunodeficiencies
TIF – Thalassaemia International Federation
EHC – European Haemophilia Consortium
EURORDIS – Rare Diseases Europe
EPTRI – European Paediatric Translational Research Infrastructure
CCI Europe – Childhood Cancer International Europe
SIOP Europe – the European Society for Paediatric Oncology
EAHAD – European Association for Haemophilia and Allied Disorders
EUCOPE – European Confederation of Pharmaceutical Entrepreneurs
Manage Cookie Consent
To provide the best experience, we use technology called cookies to store information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.